RIFABUTIN Side Effects

6992042-7 | International Normalised Ratio Increased
on Sep 07, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. Rifabutin dosage: 150mg/day. During the same period patient was treated with KLARICID (600 Mg/day) (View Klaricid Review and Klaricid Label ), CRAVIT (300 Mg/day) (View Cravit Review and Cravit Label ), PLETAL (50 Mg, 4x/day) (View Pletal Review and Pletal Label ), ARTIST (20 Mg/day) (View Artist Review and Artist Label ), WARFARIN (4.5 Mg/day) (View Warfarin Review and Warfarin Label ), AMLODIPINE BESYLATE (5 Mg/day) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ALESION (20 Mg/day) (View Alesion Review and Alesion Label ), ESANBUTOL (750 Mg/day) (View Esanbutol Review and Esanbutol Label ). Patient was hospitalized.

6978380-2 | Hypothyroidism
Patient was taking Rifabutin (View Usage). Patient had the following side effects: hypothyroidism on Sep 01, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with pulmonary tuberculosis and. Rifabutin dosage: Unk. During the same period patient was treated with P.A.S. (View P.a.s. Review and P.a.s. Label ), ETHIONAMIDE (View Ethionamide Review and Ethionamide Label ), MFLX (View Mflx Review and Mflx Label ).

6976377-X | Cardiac Failure Acute, Cardiogenic Shock
Adverse event was reported on Aug 31, 2010 by a Female patient taking Rifabutin (View Usage) (Dosage: 150 Mg, 1x/day) was diagnosed with mycobacterium avium complex infection and. Location: JAPAN , 60 years of age, After Rifabutin was administered, patient had the following side effects: cardiac failure acute, cardiogenic shock. During the same period patient was treated with EBUTOL (750mg/day) (View Ebutol Review and Ebutol Label ), KLARICID (400 Mg, 2x/day) (View Klaricid Review and Klaricid Label ), CRAVIT (Unk) (View Cravit Review and Cravit Label ), MUCOSIL 10 (15 Mg, 2x/day) (View Mucosil-10 Review and Mucosil-10 Label ), RESPLEN (Unk) (View Resplen Review and Resplen Label ), ASTHPHYLLIN (2 Df, 3x/day) (View Asthphyllin Review and Asthphyllin Label ). Patient was hospitalized.

6973717-2 | Interstitial Lung Disease
on Sep 01, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with atypical mycobacterial infection and was treated with Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Rifabutin dosage: . During the same period patient was treated with ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), AMIKACIN (View Amikacin Review and Amikacin Label ).


6955473-7 | Erythema Multiforme, Vision Blurred
on Aug 20, 2010 Female patient from JAPAN , 73 years of age, was treated with Rifabutin (View Usage). Patient had the following side effects: erythema multiforme, vision blurred. Rifabutin dosage: 300 Mg, 1x/day. During the same period patient was treated with ESANBUTOL (Unk) (View Esanbutol Review and Esanbutol Label ), LEVOFLOXACIN (Unk) (View Levofloxacin Review and Levofloxacin Label ).

6878245-0 | Abortion Spontaneous, Pregnancy
Patient was taking Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?) on Jul 16, 2010 from JAPAN Additional patient health information: Female patient , 25 years of age, weighting 103.6 lb, was diagnosed with tuberculosis (What is tuberculosis?), prophylaxis and. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with ISCOTIN (300 Mg, 1x/day) (View Iscotin Review and Iscotin Label ), PYDOXAL (20 Mg, 1x/day) (View Pydoxal Review and Pydoxal Label ), ALESION (20 Mg, 1x/day) (View Alesion Review and Alesion Label ).

6826678-0 | Abortion
Adverse event was reported on Jun 30, 2010 by a Female patient taking Rifabutin (View Usage) (Dosage: 150 Mg, 1x/day) was diagnosed with tuberculosis (What is tuberculosis?), prophylaxis and. Location: JAPAN , 25 years of age, weighting 103.6 lb, Patient experienced the following unwanted or unexpected effects: abortion (What is abortion?). During the same period patient was treated with ISCOTIN (300 Mg, 1x/day) (View Iscotin Review and Iscotin Label ), PYDOXAL (20 Mg, 1x/day) (View Pydoxal Review and Pydoxal Label ), ALESION (20 Mg, 1x/day) (View Alesion Review and Alesion Label ).

6775454-6 | Cardiac Failure Acute, Cardiogenic Shock
on Jun 08, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). Patient had the following side effects: cardiac failure acute, cardiogenic shock. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with EBUTOL (750 Mg, 1x/day) (View Ebutol Review and Ebutol Label ), KLARICID (400 Mg, 2x/day) (View Klaricid Review and Klaricid Label ), CRAVIT (200 Mg, 2x/day) (View Cravit Review and Cravit Label ), MUCOSIL 10 (15 Mg, 3x/day) (View Mucosil-10 Review and Mucosil-10 Label ), RESPLEN (20 Mg, 3x/day) (View Resplen Review and Resplen Label ), ASTHPHYLLIN (2 Df, 3x/day) (View Asthphyllin Review and Asthphyllin Label ).

6765645-2 | Respiratory Failure
on Jun 01, 2010 Female patient from JAPAN , 64 years of age, weighting 66.14 lb, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: respiratory failure. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with KLARICID (400 Mg, 2x/day) (View Klaricid Review and Klaricid Label ), CRAVIT (100 Mg, 3x/day) (View Cravit Review and Cravit Label ), AMIKACIN SULFATE (250 Mg, 3 Times Weekly) (View Amikacin Sulfate Review and Amikacin Sulfate Label ), ZITHROMAX (2 G, 1x/day) (View Zithromax Review and Zithromax Label ), OMEPRAL (20 Mg, 2x/day) (View Omepral Review and Omepral Label ), LENDORMIN (0.25 Mg, 1x/day) (View Lendormin Review and Lendormin Label ).

6750054-2 | Bone Marrow Failure
Patient was taking Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure on May 20, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, weighting 105.8 lb, was diagnosed with mycobacterium avium complex infection and. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with KLARICID (400 Mg, 2x/day) (View Klaricid Review and Klaricid Label ), EBUTOL (750 Mg, 1x/day) (View Ebutol Review and Ebutol Label ).

6750053-0 | Decreased Appetite
Adverse event was reported on May 20, 2010 by a Female patient taking Rifabutin (View Usage) (Dosage: 150 Mg, 1x/day) was diagnosed with mycobacterium avium complex infection and. Location: JAPAN , 58 years of age, weighting 112.0 lb, Patient had the following side effects: decreased appetite. During the same period patient was treated with CLARITH (Unk) (View Clarith Review and Clarith Label ), MUCODYNE (Unk) (View Mucodyne Review and Mucodyne Label ), EBUTOL (Unk) (View Ebutol Review and Ebutol Label ), CYANOCOBALAMIN (Unk) (View Cyanocobalamin Review and Cyanocobalamin Label ).

6750036-0 | Decreased Appetite
on May 20, 2010 Female patient from JAPAN , 74 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: decreased appetite. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), CLARITH (600 Mg, 1x/day) (View Clarith Review and Clarith Label ), EBUTOL (750 Mg, 1x/day) (View Ebutol Review and Ebutol Label ), CIPROFLOXACIN HCL (600 Mg, 3x/day) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), SELBEX (Unk) (View Selbex Review and Selbex Label ).

6750035-9 | Anxiety, Decreased Appetite, Malaise
on May 20, 2010 Female patient from JAPAN , 70 years of age, weighting 105.8 lb, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), decreased appetite, malaise. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with CLARITH (400 Mg, 2x/day) (View Clarith Review and Clarith Label ), CRAVIT (200 Mg, 2x/day) (View Cravit Review and Cravit Label ), LIPIDIL (Unk) (View Lipidil Review and Lipidil Label ), DEPAS (View Depas Review and Depas Label ), EBUTOL (View Ebutol Review and Ebutol Label ). Patient was hospitalized.

6733686-7 |
Patient was taking Rifabutin (View Usage). on May 11, 2010 from JAPAN Additional patient health information: Female patient , 64 years of age, weighting 66.14 lb, was diagnosed with mycobacterium avium complex infection and. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with KLARICID (View Klaricid Review and Klaricid Label ), CRAVIT (View Cravit Review and Cravit Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), OMEPRAL (View Omepral Review and Omepral Label ), LENDORMIN (View Lendormin Review and Lendormin Label ).

6710010-7 | Disseminated Intravascular Coagulation, Hyperbilirubinaemia, Pneumonia
Adverse event was reported on Apr 26, 2010 by a Male patient taking Rifabutin (View Usage) (Dosage: 300 Mg, 1x/day) was diagnosed with mycobacterium avium complex infection and. Location: JAPAN , 58 years of age, After Rifabutin was administered, patient had the following side effects: disseminated intravascular coagulation, hyperbilirubinaemia, pneumonia (What is pneumonia?). During the same period patient was treated with EBUTOL (500 Mg, 1x/day) (View Ebutol Review and Ebutol Label ), CLARITH (800 Mg, 2x/day) (View Clarith Review and Clarith Label ), ADONA (View Adona Review and Adona Label ), CHLORPHENAMINE MAL/DIHYDROCODEINE PHOSPHATE/METHYLEPHEDRINE HCL DL (Unk) (View Chlorphenamine Mal/dihydrocodeine Phosphate/methylephedrine Hcl-dl Review and Chlorphenamine Mal/dihydrocodeine Phosphate/methylephedrine Hcl-dl Label ).

6698152-6 | Disseminated Intravascular Coagulation, Hyperbilirubinaemia, Pneumonia
on Apr 15, 2010 Male patient from JAPAN , 58 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, hyperbilirubinaemia, pneumonia (What is pneumonia?). Rifabutin dosage: 300 Mg, 1x/day. During the same period patient was treated with EBUTOL (View Ebutol Review and Ebutol Label ), CLARITH (View Clarith Review and Clarith Label ), ADONA (View Adona Review and Adona Label ).

6674577-X | Intestinal Obstruction
on Mar 29, 2010 Female patient from JAPAN , 40 years of age, weighting 90.17 lb, was diagnosed with tuberculosis (What is tuberculosis?), infection (What is infection?) and was treated with Rifabutin (View Usage). Patient had the following side effects: intestinal obstruction. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with ISCOTIN (Unk) (View Iscotin Review and Iscotin Label ). Patient was hospitalized.

6648705-6 | Asphyxia
Patient was taking Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: asphyxia on Mar 12, 2010 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with mycobacterium avium complex infection and. Rifabutin dosage: 150 Unk, 1x/day. During the same period patient was treated with TRANSAMIN (View Transamin Review and Transamin Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), MEDICON (View Medicon Review and Medicon Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ), CRAVIT (View Cravit Review and Cravit Label ), CLARITH (View Clarith Review and Clarith Label ), EBUTOL (View Ebutol Review and Ebutol Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ).

6636214-X | Asphyxia
Adverse event was reported on Mar 05, 2010 by a Male patient taking Rifabutin (View Usage) (Dosage: Unk) was diagnosed with mycobacterium avium complex infection and. Location: JAPAN , 59 years of age, Patient experienced the following unwanted or unexpected effects: asphyxia. During the same period patient was treated with TRANSAMIN (View Transamin Review and Transamin Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), MEDICON (View Medicon Review and Medicon Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ), CRAVIT (View Cravit Review and Cravit Label ), CLARITH (View Clarith Review and Clarith Label ), EBUTOL (View Ebutol Review and Ebutol Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ).

6631683-3 | Respiratory Failure
on Mar 01, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). Patient had the following side effects: respiratory failure. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), KLARICID (View Klaricid Review and Klaricid Label ), TIENAM (Unk) (View Tienam Review and Tienam Label ), ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ), GARENOXACIN MESILATE (View Garenoxacin Mesilate Review and Garenoxacin Mesilate Label ), ZYVOX (Unk) (View Zyvox Review and Zyvox Label ), MIDAZOLAM (Unk) (View Midazolam Review and Midazolam Label ), VITAMINS W/AMINO ACIDS (Unk) (View Vitamins W/amino Acids Review and Vitamins W/amino Acids Label ).

6631615-8 | Intestinal Obstruction
on Mar 02, 2010 Female patient from JAPAN , 40 years of age, weighting 90.17 lb, was diagnosed with tuberculosis (What is tuberculosis?), infection (What is infection?) and was treated with Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: intestinal obstruction. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with ISCOTIN (View Iscotin Review and Iscotin Label ), ESANBUTOL (Unk) (View Esanbutol Review and Esanbutol Label ), PYRAMIDE (View Pyramide Review and Pyramide Label ). Patient was hospitalized.

6612333-9 | Condition Aggravated, Immune Reconstitution Syndrome, Tuberculosis
Patient was taking Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, immune reconstitution syndrome, tuberculosis (What is tuberculosis?) on Feb 19, 2010 from JAPAN Additional patient health information: Male patient , 37 years of age, was diagnosed with tuberculosis (What is tuberculosis?), hiv infection (What is hiv infection?) and. Rifabutin dosage: 5-20 Mg, Daily. During the same period patient was treated with NORVIR (100 Mg\day) (View Norvir Review and Norvir Label ), REYATAZ (300 Mg, Day) (View Reyataz Review and Reyataz Label ), TRUVADA (Unk) (View Truvada Review and Truvada Label ), ZITHROMAX (Unk) (View Zithromax Review and Zithromax Label ), CRAVIT (Unk) (View Cravit Review and Cravit Label ), KANAMYCIN (Unk) (View Kanamycin Review and Kanamycin Label ). Patient was hospitalized.

6608836-3 |
Adverse event was reported on Feb 17, 2010 by a Male patient taking Rifabutin (View Usage) (Dosage: 150 Mg, 1x/day) was diagnosed with mycobacterium avium complex infection and. Location: JAPAN , 70 years of age, . During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), KLARICID (View Klaricid Review and Klaricid Label ), TIENAM (Unk) (View Tienam Review and Tienam Label ), ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ), GARENOXACIN MESILATE (View Garenoxacin Mesilate Review and Garenoxacin Mesilate Label ), ZYVOX (Unk) (View Zyvox Review and Zyvox Label ), MIDAZOLAM (Unk) (View Midazolam Review and Midazolam Label ), VITAMINS W/AMINO ACIDS (Unk) (View Vitamins W/amino Acids Review and Vitamins W/amino Acids Label ).

6590810-7 | Decreased Appetite
on Feb 09, 2010 Female patient from JAPAN , 58 years of age, weighting 112.0 lb, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: decreased appetite. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with CLARITH (View Clarith Review and Clarith Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), EBUTOL (View Ebutol Review and Ebutol Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ).

6590792-8 | Decreased Appetite
on Feb 09, 2010 Female patient from JAPAN , 74 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), CLARITH (600 Mg, 1x/day) (View Clarith Review and Clarith Label ), EBUTOL (750 Mg, 1x/day) (View Ebutol Review and Ebutol Label ), CIPROXAN (600 Mg, 3x/day) (View Ciproxan Review and Ciproxan Label ), SELBEX (View Selbex Review and Selbex Label ).

6588942-2 | Decreased Appetite
Patient was taking Rifabutin (View Usage). Patient had the following side effects: decreased appetite on Feb 09, 2010 from JAPAN Additional patient health information: Female patient , 70 years of age, weighting 105.8 lb, was diagnosed with mycobacterium avium complex infection and. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with CLARITH (400 Mg, 2x/day) (View Clarith Review and Clarith Label ), CRAVIT (200 Mg, 2x/day) (View Cravit Review and Cravit Label ), LIPIDIL (View Lipidil Review and Lipidil Label ), DEPAS (View Depas Review and Depas Label ), EBUTOL (View Ebutol Review and Ebutol Label ).

6588931-8 | Bone Marrow Failure
Adverse event was reported on Feb 09, 2010 by a Female patient taking Rifabutin (View Usage) (Dosage: 150 Mg, 1x/day) was diagnosed with mycobacterium avium complex infection and. Location: JAPAN , 62 years of age, weighting 105.8 lb, After Rifabutin was administered, patient had the following side effects: bone marrow failure. During the same period patient was treated with KLARICID (View Klaricid Review and Klaricid Label ), EBUTOL (View Ebutol Review and Ebutol Label ).

6565000-4 | Hepatic Function Abnormal
on Jan 19, 2010 Male patient from JAPAN , 71 years of age, was diagnosed with mycobacterium avium complex infection, productive cough, bronchitis (What is bronchitis?) and was treated with Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with CLARITH (Unk) (View Clarith Review and Clarith Label ), ETHAMBUTOL (Unk) (View Ethambutol Review and Ethambutol Label ), CRAVIT (Unk) (View Cravit Review and Cravit Label ), SPELEAR (Unk) (View Spelear Review and Spelear Label ), THEOPHYLLINE (Unk) (View Theophylline Review and Theophylline Label ). Patient was hospitalized.

6544024-7 | Neuroleptic Malignant Syndrome
on Jan 12, 2010 Male patient from JAPAN , 61 years of age, was treated with Rifabutin (View Usage). Patient had the following side effects: neuroleptic malignant syndrome. Rifabutin dosage: Unk. During the same period patient was treated with PROMETHAZINE HCL (Unk) (View Promethazine Hcl Review and Promethazine Hcl Label ), MAGNESIUM OXIDE (Unk) (View Magnesium Oxide Review and Magnesium Oxide Label ), BROVARIN (Unk) (View Brovarin Review and Brovarin Label ), BARBITAL (Unk) (View Barbital Review and Barbital Label ), BENZALIN (Unk) (View Benzalin Review and Benzalin Label ), NEULEPTIL (Unk) (View Neuleptil Review and Neuleptil Label ), AMINOSALICYLATE CALCIUM (Unk) (View Aminosalicylate Calcium Review and Aminosalicylate Calcium Label ), CYCLOSERINE (2 Capsules/day) (View Cycloserine Review and Cycloserine Label ).

6510777-7 | Malnutrition
Patient was taking Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: malnutrition on Dec 11, 2009 from JAPAN Additional patient health information: Female patient , 76 years of age, was diagnosed with mycobacterium avium complex infection and. Rifabutin dosage: Unk. During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ).

6506811-0 | Hepatic Function Abnormal
Adverse event was reported on Dec 10, 2009 by a Female patient taking Rifabutin (View Usage) (Dosage: 150 Mg, 1x/day) was diagnosed with mycobacterium avium complex infection and. Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. During the same period patient was treated with CLARITH (Unk) (View Clarith Review and Clarith Label ), ETHAMBUTOL (Unk) (View Ethambutol Review and Ethambutol Label ), CRAVIT (View Cravit Review and Cravit Label ), SPELEAR (Unk) (View Spelear Review and Spelear Label ), THEOPHYLLINE (Unk) (View Theophylline Review and Theophylline Label ). Patient was hospitalized.

6492678-6 | Pneumonia
on Dec 02, 2009 Male patient from JAPAN , 66 years of age, weighting 138.9 lb, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with ESANBUTOL (View Esanbutol Review and Esanbutol Label ), KLARICID (View Klaricid Review and Klaricid Label ), BIOFERMIN R (View Biofermin R Review and Biofermin R Label ), GANATON (View Ganaton Review and Ganaton Label ), ZANTAC (View Zantac Review and Zantac Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ).

6455866-0 | Hepatitis Acute, Pneumonia
on Nov 13, 2009 Female patient from UNITED KINGDOM , 45 years of age, was diagnosed with tuberculosis (What is tuberculosis?), hiv infection (What is hiv infection?) and was treated with Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: hepatitis acute, pneumonia (What is pneumonia?). Rifabutin dosage: 300 Mg, 1x/day. During the same period patient was treated with TRUVADA (Unk) (View Truvada Review and Truvada Label ), PREZISTA (800 Mg, 1x/day) (View Prezista Review and Prezista Label ).

6445037-6 | Pneumonia
Patient was taking Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?) on Nov 13, 2009 from JAPAN Additional patient health information: Male patient , 66 years of age, weighting 138.9 lb, was diagnosed with mycobacterium avium complex infection and. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with ESANBUTOL (View Esanbutol Review and Esanbutol Label ), KLARICID (View Klaricid Review and Klaricid Label ), BIOFERMIN R (View Biofermin R Review and Biofermin R Label ), GANATON (View Ganaton Review and Ganaton Label ), ZANTAC (View Zantac Review and Zantac Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ).

6417386-9 | Liver Disorder, Visual Acuity Reduced
Adverse event was reported on Oct 16, 2009 by a Female patient taking Rifabutin (View Usage) (Dosage: 300 Mg, 1x/day) . Location: JAPAN , 76 years of age, Patient had the following side effects: liver disorder, visual acuity reduced. During the same period patient was treated with KLARICID (View Klaricid Review and Klaricid Label ), ETHAMBUTOL DIHYDROCHLORIDE (View Ethambutol Dihydrochloride Review and Ethambutol Dihydrochloride Label ), STREPTOMYCIN SULFATE (View Streptomycin Sulfate Review and Streptomycin Sulfate Label ), MAG LAX (View Mag-lax Review and Mag-lax Label ), CRESTOR (View Crestor Review and Crestor Label ), RHYTHMY (View Rhythmy Review and Rhythmy Label ). Patient was hospitalized.

6404180-8 | Mycobacterium Avium Complex Infection
on Oct 06, 2009 Female patient from JAPAN , 65 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: mycobacterium avium complex infection. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with CLARITH (Unk, Once Daily) (View Clarith Review and Clarith Label ), ESANBUTOL (View Esanbutol Review and Esanbutol Label ).

6376565-X |
on Sep 14, 2009 Female patient from JAPAN , 76 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). . Rifabutin dosage: Unk. During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ).

6343901-X | Eye Pain, Visual Impairment
Patient was taking Rifabutin (View Usage). Patient had the following side effects: eye pain, visual impairment on Aug 26, 2009 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with mycobacterial infection and. Rifabutin dosage: Unk. During the same period patient was treated with ESANBUTOL (Unk) (View Esanbutol Review and Esanbutol Label ), CLARITHROMYCIN (Unk) (View Clarithromycin Review and Clarithromycin Label ), RIFAMPICIN (Unk) (View Rifampicin Review and Rifampicin Label ).

6330714-8 | Bone Marrow Failure, Hepatic Function Abnormal, Pyrexia
Adverse event was reported on Aug 18, 2009 by a Female patient taking Rifabutin (View Usage) (Dosage: 450 Mg, 1x/day) was diagnosed with mycobacterium avium complex infection and. Location: JAPAN , 75 years of age, After Rifabutin was administered, patient had the following side effects: bone marrow failure, hepatic function abnormal, pyrexia. During the same period patient was treated with KLARICID (Unk) (View Klaricid Review and Klaricid Label ), PRULIFLOXACIN (Unk) (View Prulifloxacin Review and Prulifloxacin Label ), FLUTIDE DISKUS (Unk) (View Flutide Diskus Review and Flutide Diskus Label ), SEREVENT (View Serevent Review and Serevent Label ), MUCODYNE (Unk) (View Mucodyne Review and Mucodyne Label ), RANITIDINE HYDROCHLORIDE (Unk) (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ).

6325941-X | Decreased Appetite, Pyrexia
on Aug 12, 2009 Female patient from JAPAN , 69 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, pyrexia. Rifabutin dosage: 150 Mg, 1x/day. During the same period patient was treated with BIOFERMIN R (3 G, 1x/day) (View Biofermin R Review and Biofermin R Label ), MUCOSTA (300 Mg, 1x/day) (View Mucosta Review and Mucosta Label ), TOCLASE (90 Mg, 1x/day) (View Toclase Review and Toclase Label ), CLARITH (400 Mg, 1x/day) (View Clarith Review and Clarith Label ), ESANBUTOL (125 Mg, 1x/day) (View Esanbutol Review and Esanbutol Label ), RIFAMPICIN (Unk) (View Rifampicin Review and Rifampicin Label ). Patient was hospitalized.

6323149-5 | Dysgeusia, Hepatic Function Abnormal, Pyrexia
on Aug 12, 2009 Female patient from JAPAN , 62 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). Patient had the following side effects: dysgeusia, hepatic function abnormal, pyrexia. Rifabutin dosage: 450 Mg, 1x/day. During the same period patient was treated with PRULIFLOXACIN (View Prulifloxacin Review and Prulifloxacin Label ), CLARITH (View Clarith Review and Clarith Label ), RIFADIN (View Rifadin Review and Rifadin Label ), ZANTAC (View Zantac Review and Zantac Label ).

6317994-X | Eye Pain, Visual Impairment
Patient was taking Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: eye pain, visual impairment on Aug 10, 2009 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with mycobacterial infection and. Rifabutin dosage: Unk. During the same period patient was treated with ESANBUTOL (Unk) (View Esanbutol Review and Esanbutol Label ).

6312200-4 | Bone Marrow Failure, Hepatic Function Abnormal, Pyrexia
Adverse event was reported on Aug 05, 2009 by a Female patient taking Rifabutin (View Usage) (Dosage: 450 Mg, 1x/day) was diagnosed with mycobacterium avium complex infection and. Location: JAPAN , 75 years of age, Patient experienced the following unwanted or unexpected effects: bone marrow failure, hepatic function abnormal, pyrexia. During the same period patient was treated with KLARICID (Unk) (View Klaricid Review and Klaricid Label ), PRULIFLOXACIN (Unk) (View Prulifloxacin Review and Prulifloxacin Label ), FLUTIDE DISKUS (Unk) (View Flutide Diskus Review and Flutide Diskus Label ), SEREVENT (View Serevent Review and Serevent Label ), MUCODYNE (Unk) (View Mucodyne Review and Mucodyne Label ), RANITIDINE HYDROCHLORIDE (Unk) (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ).

6311557-8 | Dysgeusia, Pyrexia
on Aug 05, 2009 Female patient from JAPAN , 62 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Rifabutin (View Usage). Patient had the following side effects: dysgeusia, pyrexia. Rifabutin dosage: 450 Mg, 1x/day. During the same period patient was treated with PRULIFLOXACIN (View Prulifloxacin Review and Prulifloxacin Label ), CLARITH (View Clarith Review and Clarith Label ), RIFADIN (View Rifadin Review and Rifadin Label ), ZANTAC (View Zantac Review and Zantac Label ).

6311540-2 | Interstitial Lung Disease
on Aug 05, 2009 Female patient from JAPAN , 69 years of age, was treated with Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: interstitial lung disease. Rifabutin dosage: Unk. During the same period patient was treated with CLARITH (Unk) (View Clarith Review and Clarith Label ), ETHAMBUTOL (3 Tablets/day) (View Ethambutol Review and Ethambutol Label ), AMOBAN (View Amoban Review and Amoban Label ).

6282848-4 | Aids Cholangiopathy, Gallbladder Disorder, Hepatic Infection, Hepatic Steatosis, Hepatomegaly, Hepatotoxicity, Incorrect Dose Administered, Liver Injury, Pancreatic Disorder
Patient was taking Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: aids cholangiopathy, gallbladder disorder, hepatic infection, hepatic steatosis, hepatomegaly, hepatotoxicity, incorrect dose administered, liver injury, pancreatic disorder on Jul 22, 2009 from UNITED STATES Additional patient health information: Male patient , 42 years of age, . Rifabutin dosage: .

6282848-4 | Aids Cholangiopathy, Gallbladder Disorder, Hepatic Infection, Hepatic Steatosis, Hepatomegaly, Hepatotoxicity, Incorrect Dose Administered, Liver Injury, Pancreatic Disorder
Adverse event was reported on Jul 22, 2009 by a Male patient taking Rifabutin (View Usage) (Dosage: ) . Location: UNITED STATES , 42 years of age, Patient had the following side effects: aids cholangiopathy, gallbladder disorder, hepatic infection, hepatic steatosis, hepatomegaly, hepatotoxicity, incorrect dose administered, liver injury, pancreatic disorder.

6264129-8 | Liver Disorder
on Jun 30, 2009 Female patient from JAPAN , 82 years of age, was diagnosed with mycobacterial infection and was treated with Rifabutin (View Usage). After Rifabutin was administered, patient had the following side effects: liver disorder. Rifabutin dosage: Unk. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ).

6217295-4 | Pulmonary Tuberculosis
on Apr 13, 2009 Female patient from JAPAN , 77 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifabutin (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary tuberculosis. Rifabutin dosage: 300 Mg, 1x/day. During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), KLARICID (View Klaricid Review and Klaricid Label ), HUMULIN R (View Humulin R Review and Humulin R Label ), LAMISIL (View Lamisil Review and Lamisil Label ), SENNARIDE (Unk) (View Sennaride Review and Sennaride Label ).

5799386-5 | Renal Impairment
Patient was taking Rifabutin (View Usage). Patient had the following side effects: renal impairment on Jun 24, 2008 from UNITED KINGDOM Additional patient health information: Male patient , weighting 97.00 lb, . Rifabutin dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ). Patient was hospitalized.